Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Concordance Between FFR and iFR for the Assessment of Intermediate Lesions in the Left Main Coronary Artery. A Prospective Validation of a Default Value for iFR (iLITRO Study)

NCT03767621 is registered in ClinicalTrials.gov with Fundación EPIC as lead sponsor.

NCT NCT03767621
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03767621 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Concordance Between FFR and iFR for the Assessment of Intermediate Lesions in the Left Main Coronary Artery. A Prospective Validation of a Default Value for iFR (iLITRO Study)
Lead sponsor
Fundación EPIC
Phase
Observational
Overall status
Active, not recruiting
Start date
February 19, 2019
Completion date
November 30, 2026
Enrollment
300 (estimated)
Sites
38

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, left main coronary artery disease, left main coronary artery stenosis, restenosis, coronary